Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma

Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma

ABSTRACTRenal cell carcinoma (RCC), especially clear cell RCC, is generally considered an immunotherapy-responsive cancer. Recently, the prognosis for patients with locally advanced and metastatic RCC has significantly improved with the regulatory approvals of anti-PD-1/PD-L1/CTLA-4 immune checkpoin...

Full description

Saved in:
Bibliographic Details
Main Authors: Albert Jang (Author), Jake N. Lichterman (Author), Jeffrey Y. Zhong (Author), Jonathan E. Shoag (Author), Jorge A. Garcia (Author), Tian Zhang (Author), Pedro C. Barata (Author)
Format: Book
Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items